Oxamic acid thiohydrazides and hydrazones based on them as convenient starting compounds for the synthesis of S- and N-containing heterocyclic products. A mini-review DOI Creative Commons

М. М. Krayushkin,

V. N. Yarovenko

Arabian Journal of Chemistry, Journal Year: 2024, Volume and Issue: 17(6), P. 105796 - 105796

Published: April 20, 2024

The chemistry of hydrazones is currently undergoing intensive development. For example, thioacylhydrazones, which are synthesized most often from thiosemicarbazides, have become very popular in recent years owing to impressive results their extensive testing medicinal chemistry. Their antiviral, insecticidal, antisclerotic, antioxidant, and antiparasitic activities been demonstrated; thioacylhydrazones showed promise for the development drugs against COVID-19 HIV. ligands based on these compounds with soft donor nitrogen sulfur atoms widely used creation complexes various bioactivities, including strong anticancer properties. Since replacement oxygen atom a may increase biological activity compound, desire expand spectrum pharmacological action or change type induces understandable interest thio analogues acylhydrazones that known high bioactivity. At same time, there publications indicating oxamic acid thiohydrazides containing thioamide thiohydrazide moieties, due polyfunctional nature, can be effectively synthesis wide variety compounds, bioactive products. This review describes synthetic applied potential poorly investigated them. A considerable benefit derivatives presence an additional carboxamide group, itself significant processes also easily modified, thus providing wealth combinations new promising convenient methods preparation this demonstrates large potential, opens up way thiohydrazone heterocyclic new-generation antibacterial targeting secretory system bacteria, suppressing infectious process eliminating pathogen body without affecting proliferation bacteria.

Language: Английский

Advances in thiosemicarbazone metal complexes as anti-lung cancer agents DOI Creative Commons
Xianguang Bai, Yunyun Zheng, Jinxu Qi

et al.

Frontiers in Pharmacology, Journal Year: 2022, Volume and Issue: 13

Published: Sept. 27, 2022

The great success of cisplatin as a chemotherapeutic agent considerably increased research efforts in inorganic biochemistry to identify more metallic drugs having the potential treating lung cancer. Metal coordination centres, which exhibit wide range numbers and geometries, various oxidised reduced states inherent ligand properties offer pharmaceutical chemists plethora drug structures. Owing presence C=N C=S bonds thiosemicarbazone Schiff base, N S atoms its hybrid orbital has lone pair electrons, can generate metal complexes with different stabilities most elements under certain conditions. Such ligands play key roles treatment anti-lung Research regarding cancer advanced considerably, but there remain several challenges. In this review, we discuss base drugs, their anti-cancer activities likely action mechanisms involving recent families copper, nickel, platinum, ruthenium other complexes.

Language: Английский

Citations

42

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin DOI
Zhenlei Zhang, Juzheng Zhang,

Tongfu Yang

et al.

Journal of Medicinal Chemistry, Journal Year: 2023, Volume and Issue: 66(8), P. 5669 - 5684

Published: April 18, 2023

To develop the next-generation Pt drug with remarkable activity and low toxicity to maximally inhibit tumor growth, we optimized a Pt(II) thiosemicarbazone compound (C4) cytotoxicity SK-N-MC cells then constructed new human serum albumin-C4 (HSA-C4) complex delivery system. The in vivo results showed that C4 HSA-C4 have therapeutic efficiency almost no toxicity; they induced apoptosis inhibited angiogenesis. This system potential as practical drug. study could pave way for developing dual-targeted drugs achieving their targeting therapy cancer.

Language: Английский

Citations

37

Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis DOI
Xiaojun Wang,

Minghui Zhu,

Shanhe Li

et al.

Journal of Inorganic Biochemistry, Journal Year: 2023, Volume and Issue: 250, P. 112403 - 112403

Published: Oct. 17, 2023

Language: Английский

Citations

15

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance DOI Open Access

Vivien Pósa,

Alessia Stefanelli, Julia H. Bormio Nunes

et al.

Cancers, Journal Year: 2022, Volume and Issue: 14(18), P. 4455 - 4455

Published: Sept. 14, 2022

COTI-2 is currently being evaluated in a phase I clinical trial for the treatment of gynecological and other solid cancers. As thiosemicarbazone, this compound contains an N,N,S-chelating moiety is, therefore, expected to bind endogenous metal ions. However, besides zinc, interaction properties have not been investigated detail so far. This unexpected, as we recently shown that forms stable ternary complexes with copper glutathione, which renders drug substrate resistance efflux transporter ABCC1. Herein, complex formation COTI-2, two novel terminal N-disubstituted derivatives (COTI-NMe

Language: Английский

Citations

19

A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death DOI
Wenjuan Li, Shanhe Li, Xueyu Man

et al.

Rare Metals, Journal Year: 2024, Volume and Issue: unknown

Published: July 22, 2024

Language: Английский

Citations

4

Development a stannum(IV) 8-quinolinecarbaldehyde thiosemicarbazone complex with remarkable anticancer activity via pyroptosis and apoptosis DOI
Xiaoling Wu, Jinhui Pang, Wenjuan Li

et al.

Journal of Molecular Structure, Journal Year: 2025, Volume and Issue: unknown, P. 142225 - 142225

Published: March 1, 2025

Language: Английский

Citations

0

Anticancer potential of PtL2: A steroid-thiosemicarbazone platinum(II) complex for breast cancer therapy DOI
Jorge M. Herrero,

Francisco Aguilar-Rico,

Ana I. Matesanz

et al.

Journal of Inorganic Biochemistry, Journal Year: 2025, Volume and Issue: unknown, P. 112923 - 112923

Published: April 1, 2025

Language: Английский

Citations

0

Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes DOI Open Access
Xiaohua Jiang, Lauren Fielding, Hunter C. Davis

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(15), P. 12010 - 12010

Published: July 27, 2023

Topoisomerases, common targets for anti-cancer therapeutics, are crucial enzymes DNA replication, transcription, and many other aspects of metabolism. The potential effects thiosemicarbazones (TSC) metal-TSC complexes have been demonstrated to target several biological processes, including Human topoisomerases were discovered among the molecular TSCs, metal-chelated TSCs specifically displayed significant inhibition topoisomerase II. processes by which metal-TSCs or inhibit still being studied. In this brief review, we summarize that various types human topoisomerases, note some key unanswered questions regarding interesting class diverse compounds.

Language: Английский

Citations

8

Synthesis, Structures, and Solution Studies of a New Class of [Mo2O2S2]-Based Thiosemicarbazone Coordination Complexes DOI Creative Commons
Arcadie Fuior, Diana Cebotari, Mohamed Haouas

et al.

ACS Omega, Journal Year: 2022, Volume and Issue: 7(19), P. 16547 - 16560

Published: May 3, 2022

This paper deals with the synthesis, structural studies, and behavior in solution of unprecedented coordination complexes built by association a panel 14 representative thiosemicarbazone ligands cluster [Mo2O2S2]2+. These have been thoroughly characterized both solid state XRD NMR, respectively. In particular, HMBC 1H{15N} 1H DOSY NMR experiments bring important elements for understanding complexes' solution. studies demonstrate that playing on nature position various substituents strongly influences modes as well numbers isomers solution, mainly 2 products majority up to 5 some them.

Language: Английский

Citations

13

Dithiobiureas Palladium(II) complexes' studies: From their synthesis to their biological action DOI
Jorge M. Herrero, David Fabra, Ana I. Matesanz

et al.

Journal of Inorganic Biochemistry, Journal Year: 2023, Volume and Issue: 246, P. 112261 - 112261

Published: May 24, 2023

Language: Английский

Citations

7